Cargando…
Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?
PURPOSE OF REVIEW: Exciting pre-clinical data presents pluripotent stem cell-derived cardiomyocytes (PSC-CM) as a novel therapeutic prospect following myocardial infarction, and worldwide clinical trials are imminent. However, despite notable advances, several challenges remain. Here, we review PSC-...
Autores principales: | Selvakumar, Dinesh, Reyes, Leila, Chong, James J. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068652/ https://www.ncbi.nlm.nih.gov/pubmed/35275365 http://dx.doi.org/10.1007/s11886-022-01666-9 |
Ejemplares similares
-
Formation of the Heart: Defining Cardiomyocyte Progenitors at Single-Cell Resolution
por: Tyser, Richard C. V.
Publicado: (2023) -
Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells
por: Khedro, Tarek, et al.
Publicado: (2022) -
Modeling Cardiac SARS-CoV-2 Infection with Human Pluripotent Stem Cells
por: Rockwood, Sarah J., et al.
Publicado: (2022) -
Role of Mononuclear Cardiomyocytes in Cardiac Turnover and Regeneration
por: Becker, Cora, et al.
Publicado: (2020) -
The Role of Innate Immune Cells in Cardiac Injury and Repair: A Metabolic Perspective
por: Banerjee, Durba, et al.
Publicado: (2023)